Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384579 · ClinicalTrials.gov registry record · Phase 4
Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain
A Phase 4 study, sponsored by United States Department of Defense.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00384579: Clinical Trial Phase 4 study, sponsored by United States Department of Defense.
NCT00384579 is a Phase 4 study that was terminated before completion, run by United States Department of Defense. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00384579, a Phase 4 study, was terminated before completion, sponsored by United States Department of Defense.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
This study will test the hypothesis that Botulinum toxin B (Myobloc®) treatment reduces pain and disability in subjects suffering from acute low back pain due to an identifiable muscle strain or back trauma occurring 3 to 6 weeks prior to enrollment. The study will also delineate the duration of medication effect and control for any placebo or mechanical trigger-point injection effect by employing a prospective, double-blind, placebo-controlled design.
Interventions
- DRUG Placebo
- DRUG Botulinum toxin B
Trial Details
| Field | Value |
|---|---|
| Start Date | 2008-02 |
| Est. Completion | 2010-08 |
| Phase | Phase 4 |
Why NCT00384579 stopped before completion
NCT00384579 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00384579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00384579 about?
NCT00384579 is a clinical study titled "Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain". This study will test the hypothesis that Botulinum toxin B (Myobloc®) treatment reduces pain and disability in subjects suffering from acute low back pain due to an identifiable muscle strain or back trauma occurring 3 to 6 weeks prior to enrollment. The study will also delineate the duration of med...
What is the current status of trial NCT00384579?
This trial is currently terminated. It is a Phase 4 study. The study started on 2008-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00384579?
The interventions under investigation include: Placebo (DRUG), Botulinum toxin B (DRUG).
Who is sponsoring clinical trial NCT00384579?
This trial is sponsored by United States Department of Defense, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia